Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (B32000)
Medtronic, Inc. · Decision date Nov 8, 2026
What did the FDA approve?
This supplement covers a change to the dimensions of a lead insertion tool associated with Medtronic’s deep brain stimulation system, together with a change to verification testing of the tool’s tip width.
FDA records S545 as a Real-Time Process supplement to PMA P960009. Its scope is the tool modification described in this filing; the system’s original approval is recorded separately under P960009.
FDA approval order statement
approval for dimensions size change for lead insertion tool and modification to tip width dimension verification testing.
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Neurology
- Decision date
- Nov 8, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P960009/S545
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic, Inc.
- Product code
- MHY
- Decision code
- APPR
- Decision date
- Nov 8, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, electrical, implanted, for parkinsonian tremor.
- Applicant
- Medtronic, Inc.
- Product code
- MHY
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P960009. Subsequent supplements may change the device or its indications.
FDA decision timeline
P960009 · Original PMA
MEDTRONIC ACTIVA TREMOR CONTROL SYSTEM
P960009/S545 received
Application receipt date recorded by FDA.
P960009/S546 · Related supplement
MEDTRONIC ACTIVA TREMOR CONTROL SYSTEM
P960009/S542 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S547 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (DBS Neurostimulator Implantable B35200)
P960009/S548 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S545 · FDA decision
Real-Time Process
Timeline entries are records held by MedtechLedger for P960009. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P960009
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic, Inc. | PMA approval | Jul 31, 1997 | FDA | |
MEDTRONIC ACTIVA TREMOR CONTROL SYSTEMP960009/S546 | Medtronic, Inc. | PMA supplement | Sep 24, 2026 | FDA |
| Medtronic, Inc. | PMA supplement | Oct 6, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 29, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 30, 2026 | FDA |
Explore the linked device profile
Other records with product code MHY
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2026 | FDA | |
Deep Brain Stimulation (DBS) EPGP140009/S141 | ABBOTT MEDICAL | PMA supplement | Oct 28, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Oct 27, 2026 | FDA | |
Infinity DBS IPGP140009/S139 | ABBOTT MEDICAL | PMA supplement | Sep 23, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 7000 Central Ave., NE, Minneapolis, MN, 55432
Sources and methodology
- Original FDA record: P960009/S545
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
